Imbed Biosciences Inc. (Imbed), a privately held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers and surgical wounds, announced today that it ...
MADISON, Wis.--(BUSINESS WIRE)--Imbed Biosciences Inc. (Imbed), a medical device company emerging as a leader in the development of advanced therapies for soft tissue repair, announced today that it ...
BioLab Holdings, Inc., a Phoenix‑based medical manufacturer specializing in advanced wound protection technologies, has announced a strategic investment in Imbed Biosciences, Inc., the Wisconsin‑based ...
MIDDLETON, Wis., Aug. 28, 2025 /PRNewswire/ -- Imbed Biosciences Inc., a leader in advanced wound care technology, today announced the launch of SAM™ PainGuard™ with Lidocaine, a groundbreaking ...
Imbed Biosciences Inc. (Imbed), a developer of next-generation therapies for tissue repair, and Spartan Medical, a veteran-owned Federal Contractor with fourteen years of flawless performance, jointly ...
Investigational Device Exemption (IDE) enables Imbed’s Silver-Gallium, Ultra-Thin Matrix Technology to be tested in human clinical studies, a key step towards marketing approval Fully synthetic, ...
Imbed Biosciences, Inc. (Imbed) announced today that it has been awarded a $1.5 million two-year Small Business Innovation Research (SBIR) grant from the National Institute for Arthritis and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results